These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 6927748)
1. Validation and routine operation of a sterile dry powder filling facility. Prout G J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748 [No Abstract] [Full Text] [Related]
2. Design control and validation of a facility for sterile clinical trial preparations. Staines L J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778 [No Abstract] [Full Text] [Related]
3. [Validation of sterile pharmaceutical production. Considerations and experiences]. Pongiluppi S Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520 [No Abstract] [Full Text] [Related]
4. Filling vials aseptically while monitoring for bacterial contamination. Dirksen JW; Larsen RV Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216 [TBL] [Abstract][Full Text] [Related]
5. [Flow of laminar air: use in sterile rooms]. Lumini E Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445 [No Abstract] [Full Text] [Related]
7. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures]. Anastasio P; Carazzone M; Genova R; Malesani L; Molinari ML Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577 [No Abstract] [Full Text] [Related]
8. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
9. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control. Elias WF Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322 [No Abstract] [Full Text] [Related]
10. Biological indicators in the pharmaceutical and the medical device industry. Pflug IJ; Odlaug TE J Parenter Sci Technol; 1986; 40(5):242-8. PubMed ID: 3540254 [No Abstract] [Full Text] [Related]
11. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production]. Ghirardini M; Falini R Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099 [No Abstract] [Full Text] [Related]
12. An approach to establishing parenteral solution sterilization cycles. Korczynski MS; Peterson CL; Loshbaugh CC Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323 [No Abstract] [Full Text] [Related]
13. The influence of clean room design on product contamination. Whyte W J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777 [No Abstract] [Full Text] [Related]
14. [Validation of procedure for sterile manufacturing. Simulated distribution in containers, in a sterile area]. Arecco D; Carazzone M; Fava M Boll Chim Farm; 1982 Oct; 121(10):493-502. PubMed ID: 7165749 [No Abstract] [Full Text] [Related]
17. Design and operation of an in-house pyrogen test facility. Armistead RL; Taylor NL Bull Parenter Drug Assoc; 1977; 31(1):14-7. PubMed ID: 831894 [No Abstract] [Full Text] [Related]
18. Microbial identification strategies in the pharmaceutical industry. Cundell AM PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194 [TBL] [Abstract][Full Text] [Related]
19. [Microbiologic validation in the production of sterile pharmaceuticals]. Pongiluppi S Boll Chim Farm; 1991 Jun; 130(6):203-12. PubMed ID: 1756004 [TBL] [Abstract][Full Text] [Related]
20. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring. Raiman HL Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742 [No Abstract] [Full Text] [Related] [Next] [New Search]